Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126992872 | 12699287 | 2 | F | 2016 | 20160825 | 20160830 | 20160907 | EXP | US-CELGENEUS-USA-2016032861 | CELGENE | 69.90 | YR | F | Y | 0.00000 | 20160907 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126992872 | 12699287 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | 100 MILLIGRAM | U | UNKNOWN | 20785 | 50 | MG | CAPSULES | BID | ||||
| 126992872 | 12699287 | 2 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | Oral | 0 | 100 | MG | UNKNOWN | BID | |||||||
| 126992872 | 12699287 | 3 | C | Iron | IRON | 1 | Oral | 0 | 324 | MG | UNKNOWN | QD | |||||||
| 126992872 | 12699287 | 4 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | Unknown | 0 | 180 | MG | UNKNOWN | QD | |||||||
| 126992872 | 12699287 | 5 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126992872 | 12699287 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 0 | 1 | DF | UNKNOWN | BID | |||||||
| 126992872 | 12699287 | 7 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 0 | 1 | MG | UNKNOWN | QD | |||||||
| 126992872 | 12699287 | 8 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 0 | 25 | MG | UNKNOWN | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126992872 | 12699287 | 1 | Plasma cell myeloma |
| 126992872 | 12699287 | 2 | ADAMTS13 activity decreased |
| 126992872 | 12699287 | 3 | Product used for unknown indication |
| 126992872 | 12699287 | 4 | Asthma |
| 126992872 | 12699287 | 5 | Multiple allergies |
| 126992872 | 12699287 | 6 | Chronic obstructive pulmonary disease |
| 126992872 | 12699287 | 7 | Anaemia |
| 126992872 | 12699287 | 8 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126992872 | 12699287 | DE |
| 126992872 | 12699287 | HO |
| 126992872 | 12699287 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126992872 | 12699287 | Death | |
| 126992872 | 12699287 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126992872 | 12699287 | 1 | 20160112 | 20160319 | 0 | |
| 126992872 | 12699287 | 2 | 201510 | 0 | ||
| 126992872 | 12699287 | 3 | 201509 | 0 | ||
| 126992872 | 12699287 | 7 | 201509 | 0 |